Who we are

Board of Directors

Name……………………..Role………………………..Mini Bio
Stéphane ThiroloixStéphane ThiroloixFounder, President & CEOHEC. Board Member at Jellagen. Prev CEO Mayoly-Spindler, EVP Europe Smith&Nephew, EVP Corporate Development IPSEN.
Olivier BohuonCo-FounderChairman of the Board Majorelle. Board Member Takeda, Virbac, Reckitt.
Thibaut RoulonThibaut RoulonMember, BODSenior Investment Director – Life Sciences, Bpifrance. Graduate Ecole Centrale Paris, PhD in Molecular Biophysics P&M Curie University.
Guillaume BlavierMember, BODAssociate at Omnes Capital. PharmD Rouen University, MS Audencia
Bervin BouaniMember, BODInvestment Director,Turenne
Pauline de BreteuilMember, BODSenior Partner
Innovation, Majic / UI Investissement
Hugues Le BretHugues Le BretMember, BODFounder & Supervisory Board President Compte-Nickel. Adviser to CEO BNP Paribas. Prev President & CEO Boursorama.
Scott ByrdIndependent Member, BODCEO Pioneer Tx, CoB of Acacia Pharma Group.
BS in mechanical eng. & MBA Harvard University.
Ed HarriganIndependent Member, BODBoard Mb at Acadia, Incyte and Phase Bio.
Sc Advisor to Alzheon and Karuna Tx.
BA St Anselm, MD Massachusetts University, Neurology Boston University.

Executive Team

Name……………………..Role……………………..Mini Bio
Stéphane ThiroloixStéphane ThiroloixFounder, President & CEOHEC. Board Member at Jellagen. Prev CEO Mayoly-Spindler, EVP Europe Smith&Nephew, EVP Corporate Development IPSEN.
Philippe PicautChief Development OfficerPharm D, MSc Tox, MSc Anatomopathology, American Board of Toxicology.
Sr VP Neurosciences R&D, Ipsen.
Gabriel FoxChief Medical OfficerMD. Postgrad Dip Mktg. CMO, Acacia Pharma. Int Med Leader and Head, Gbl Onc Mktg, Roche. Med Dir, NeXstar/Gilead.
Etienne BienfaitEtienne BienfaitChief Financial OfficerEngineer, Research Master in Business Mgt. Covage, Bryan Garnier.
Agathe NadolnyChief Project Mgt OfficerMSc, PMP®. Chief Project Management Officer. Previously New Pdt Plng Mgr Mayoly-Spindler, PMO Mgr Bio-Rad.
France CatusFrance CatusClinical Operations ManagerMD. Statistics DIU (Cesam). Ipsen Medical Dvt Dir, Clin Dvt Dir.
Julie LeibreichClinical Operation Project ManagerBio. Sc., Clinical Research. Clinical Project Mgt certification. Clinical Project Mgr Medday Pharma
Steve ScottSteve ScottUS Regulatory OfficerFounder, PDR for Pharma. Ipsen VP North American Reg Aff,Biomeasure, Pharma Dvt Resources, Sepracor, Parexel, Interferon Sciences.

Scientific Advisory Board

Name……………………..Role…………Mini BIo
Céline GrecoCéline GrecoChair, SABMD PhD. Hosp. Practitioner, Dpt of neonatal, pediatric & adult pain and palliative medicine, Hop Necker Enfants Malades, Paris, France.
Guido CavalettiMember, SABMD. Prof Neurology, San Gerardo Hosp, Monza. BoD of Peripheral Nerve Society, Chair of Toxic Neuropathy Consortium, Intl Peri-Noms group in CIPN.
David CornblathMember, SABMD. Prof Neurology, Johns Hopkins. BoD of Peripheral Nerve Society, BoD Foundation for Peripheral Neuropathy.
Jean DeregnaucourtMember, SABDVM, Post Doc UCLA. Ex RPR, Pierre Fabre R&D, Dir Biotech French Min. Research, Research Apps Institut Pasteur.
Roy Freeman Roy Freeman Member, SAB MD. Prof Neurology, Harvard Med School. Dir Cntr for Autonomic and Periph Nerve Disorders at Beth Israel Deaconess Medical Ctr, Boston, Ma.
Axel Le CesneAxel Le CesneMember, SABAssoc Prof of Medicine. Head of Medical Onclogy Hospital Unit, Gustave Roussy, France.
Curtis RosebraughMember, SABMD, Ex CDER Director Office of Drug Evaluation II : DPARP, DMEP & Div of Anesthesia, Analgesia & Addiction Products.